Last reviewed · How we verify

NCT05206240

Extracorporeal Shock Wave Therapy and Assessment Strategy Through a Novel Gait Analysis Tool for Post-stroke Spasticity

Completed Last updated 16 February 2023
What this trial tests

trial testing Radial extracorporeal shock wave therapy and conventional physical therapy in Stroke, Ischemic in 15 participants. Completed in 1 August 2022.

Timeline
1 March 2021
Primary endpoint
1 June 2022
1 August 2022

Quick facts

Lead sponsorCarol Davila University of Medicine and Pharmacy
StatusCompleted
Study typeOBSERVATIONAL
Enrollment15
Start date1 March 2021
Primary completion1 June 2022
Estimated completion1 August 2022
Sites1 location across Romania

Drugs / interventions tested

Conditions studied

Sponsor

Carol Davila University of Medicine and Pharmacy

Who can join

18 and older, any sex, with Stroke, Ischemic or Stroke Hemorrhagic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to objectively evaluate the effectiveness of radial extracorporeal shock wave therapy (rESWT) and conventional physical therapy program on the gait pattern through a new gait analysis system which encompasses spatiotemporal and kinematic parameters and to correlate the findings with the clinical evaluation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Conventional physical therapy combined with extracorporeal shock wave leads to positive effects on spasticity in stroke survivors: a prospective observational study.
    Mihai EE, Papathanasiou J, Panayotov K, Kashilska Y, et al · · 2023 · cited 2× · PMID 37667862 · DOI 10.4081/ejtm.2023.11607

Verify or expand the search:

Other recruiting trials for Stroke, Ischemic

Currently open trials in the same condition.

Other Carol Davila University of Medicine and Pharmacy trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05206240.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing